Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.195
-0.045 (-3.63%)
Mar 27, 2026, 11:25 AM EDT - Market open

Pulmonx Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
50922704913171,184
Market Cap Growth
-82.67%-65.91%-44.99%55.12%-73.27%-51.92%
Enterprise Value
38.9977.24224.1412.09196.41,028
Last Close Price
1.202.216.7912.758.4332.07
PE Ratio
--1.66-4.72-7.97-5.30-23.76
PS Ratio
0.581.023.227.155.9024.46
PB Ratio
0.951.703.154.152.066.13
P/TBV Ratio
0.901.663.104.092.036.00
P/FCF Ratio
--2.81-8.19-12.78-6.82-26.29
P/OCF Ratio
--2.84-8.57-13.06-7.02-28.62
EV/Sales Ratio
0.430.852.676.003.6621.24
EV/EBITDA Ratio
--1.47-3.99-6.82-3.44-22.15
EV/EBIT Ratio
--1.44-3.88-6.65-3.35-21.74
EV/FCF Ratio
--2.35-6.79-10.73-4.23-22.82
Debt / Equity Ratio
1.021.020.650.320.140.13
Debt / EBITDA Ratio
-1.07-1.07-1.00-0.69-0.43-0.57
Debt / FCF Ratio
-1.72-1.72-1.71-1.08-0.53-0.59
Net Debt / Equity Ratio
-0.25-0.25-0.53-0.64-0.76-0.80
Net Debt / EBITDA Ratio
0.260.260.811.262.053.31
Net Debt / FCF Ratio
0.420.421.371.982.523.41
Asset Turnover
0.620.620.490.370.250.19
Inventory Turnover
1.231.231.150.920.760.95
Quick Ratio
4.094.094.705.598.1110.65
Current Ratio
5.075.075.586.509.1411.85
Return on Equity (ROE)
-77.19%-77.19%-55.25%-44.68%-33.94%-23.21%
Return on Assets (ROA)
-37.17%-37.17%-34.18%-33.66%-27.51%-19.10%
Return on Invested Capital (ROIC)
-133.02%-133.02%-139.41%-156.34%-152.77%-154.31%
Return on Capital Employed (ROCE)
-43.34%-43.34%-39.38%-37.56%-29.86%-20.18%
Earnings Yield
-103.11%-60.18%-21.21%-12.55%-18.86%-4.21%
FCF Yield
-62.68%-35.64%-12.21%-7.82%-14.66%-3.80%
Buyback Yield / Dilution
-4.03%-4.03%-2.99%-2.37%-2.68%-254.74%
Total Shareholder Return
-4.03%-4.03%-2.99%-2.37%-2.68%-254.74%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q